Navigation Links
'Just do it!' not good enough for cancer patients, UR researchers say
Date:5/30/2012

Exercise generally helps the nation's 12 million cancer survivors, but researchers are still working toward being able to prove, with scientific certainty, that prescriptions for daily yoga or 20 minutes of walking will likely extend a patient's survival.

Understanding specifically how exercise benefits subpopulations of cancer patients is among the big topics at the American Society of Clinical Oncology (ASCO) 2012 annual meeting in Chicago, June 1-5, 2012. Several scientists from the James P. Wilmot Cancer Center at the University of Rochester Medical Center are part of the ASCO discussion, including Lisa K. Sprod, Ph.D., a junior faculty member who is being recognized with an ASCO Merit Award.

"In 15 years we've gone from being afraid to recommend exercise to people with cancer, to having enough data that shows, by and large, it is safe and effective, particularly for relief of treatment side effects," said Karen Mustian, Ph.D., M.P.H., assistant professor of Radiation Oncology at URMC and an exercise psychologist specializing in cancer. "But when a patient walks in the door, he or she wants to know how to tailor exercise to their own situation. Should I bike, walk, or lift weights? Is there anything I should avoid? Can certain exercises lower my fatigue? And the scientific community has not settled into a place where we've developed explicit exercise prescriptions, or can effectively narrow the choices for patients."

Several URMC suggest that knowing how to develop and apply specific exercise programs (dose and timing to achieve a certain outcome) is a realistic goal.

Mustian and Sprod investigated physical activity among older people, a group they describe as often overlooked and underestimated in terms of their ability to live with cancer. On June 2 at ASCO they will present two studies in a session titled, Staying Bold While Old:

Mustian conducted a phase II clinical trial to discover whether six weeks of a home
'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Its Not Just What You Eat, Its When You Eat, Mouse Study Finds
2. A Heart Disease Veteran at Just Age 12
3. Adjusting Your Attitude About Chronic Pain May Help You Sleep
4. Aromatherapy: More Than Just a Pleasant Scent?
5. Some Folks Just Cant Help Being Nice, Study Suggests
6. Being Ignored Feels Just as Bad Online
7. Justices Meet to Decide Fate of Health-Reform Legislation
8. Accidents dont just happen: New Book on trends and takeaways in injury research
9. Very good experiences dont just happen for patients
10. Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer
11. Teens of Lesbian Parents Appear Well-Adjusted
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014 USARAD Holdings Inc. a ... solutions provider, including SecondOpinions.com® – consumer division is ... advanced services. The telemedicine industry pioneer is now ... , Founded and established in 1963 as the ... began as a maternity care hospital with very ...
(Date:9/2/2014)... to announce that the following papers will be ... Congress 2014, taking place in Barcelona, Spain, 30 ... strut biodegradable polymer sirolimus-eluting stent versus durable polymer ... randomised, single-blind, non-inferiority trial, Windecker et al ... surface polymer, and drug release have improved clinical ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 The global ... USD 8,918.8 million by 2020, growing at an estimated ... a new study by Grand View Research, Inc. Peripheral ... plague modification devices are used for treating peripheral arterial ... of atherosclerotic plaques in arteries. These devices are used ...
(Date:9/2/2014)... Denver, Colo. (PRWEB) September 02, 2014 ... reimagined patient care, has been selected from a group ... round of the 2014 PrIME Digital Health Challenge. The ... against one another, Tuesday, Sept. 9th at the CSU ... in 2012, MyRounding is based in Denver, Colo. The ...
(Date:9/2/2014)... Headaches, both chronic and acute ruin lives. They can ... friends, sleeping and just coping well with daily activities. ... worldwide. The medications prescribed for these conditions frequently don’t ... cases of headache and back pain are of a mechanical ... detect and fix the cause. , When a sports ...
Breaking Medicine News(10 mins):Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4Health News:The Lancet: European Society of Cardiology Congress 2014 media alert 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:MyRounding Selected for Digital Health Venture Showcase Finals Top Three Startups Awarded $50,000 2Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2
... you,re ready to drive again , , WEDNESDAY, Dec. 10 (HealthDay ... wheel again after orthopedic surgery or injury, but knowing when it,s ... , Orthopedic surgeons weigh in on the issue in the December ... , "Deciding when a patient can return to driving is ...
... (OTC Pink Sheets: SNDY ) is pleased to announce that ... by over 10% compared to the same time period for 2007. ... $28,509 for the same month last year. This marks the second ... of October. , , The Mammo ...
... Inc., a leading,provider of software and databases for systems ... Singapore Immunology Network (SIgN) has become a,certified GeneGo Center ... MetaCore, training and advanced support. SIgN COE will ... "We are excited ...
... Facilities , , NEW ... process, a proven commitment to clinical quality earned SigmaCare(R) ... Metropolitan Jewish Health System,s (Metropolitan) skilled nursing facilities. ... nationally recognized nonprofit organization, operates Metropolitan Jewish Geriatric Center, ...
... Pharma Services, Goodwill, , , ... NYSE: MDZ ), a leading provider of products and ... fiscal 2008 performance. , Based on preliminary information, MDS ... of $1,210 million to $1,220 million and adjusted EBITDA in the ...
... Care Insurance While They,re Still Healthy Enough to Qualify , ... If you,ve put off getting long term care insurance, ... new administration,s health plan? "I wouldn,t advise it," says Denise ... (LTCFP), one of the nation,s most experienced long term care ...
Cached Medicine News:Health News:Returning to the Road Tricky After Injury 2Health News:Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year 2Health News:A*STAR's Singapore Immunology Network Is the First GeneGo Center of Excellence in Asia 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 2Health News:Metropolitan Jewish Health System Awards Electronic Medical Records Contract to SigmaCare(R) 3Health News:MDS Provides Update on Fiscal 2008 Performance 2Health News:MDS Provides Update on Fiscal 2008 Performance 3Health News:MDS Provides Update on Fiscal 2008 Performance 4Health News:Obama Health Plan Not Likely to Embrace Long Term Care, Industry Leader Says 2
(Date:9/2/2014)... -- ResMed (NYSE: RMD ) has introduced the ... the United States . The Astral platform is ... support ventilators. ResMed,s new Astral life ... for patients suffering from neuromuscular disease, chronic obstructive pulmonary ... The U.S. launch comes on the heels of Astral,s ...
(Date:9/2/2014)... 2014   Mast Therapeutics, Inc . (NYSE MKT: MSTX) today ... , will present at the Rodman and Renshaw 16 th ... p.m. Eastern time in the Holmes II Salon at The New ... Interested parties can access a live audio webcast and ... . An archived presentation will be available on the web site ...
(Date:9/2/2014)... Sept. 2, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... products marketed as XIAFLEX ® in the U.S. and ... President, Tom Wegman , will present at the following ... Rodman & Renshaw 16 th Annual ... Tuesday, September 9, 2014 at 9:10 a.m. EDT ...
Breaking Medicine Technology:ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2
... SEATTLE, Jan. 13, 2011 Dendreon Corporation (Nasdaq: ... market and other conditions, $500 million aggregate principal amount of ... an offering registered under the Securities Act of 1933, as ... cash, shares of Dendreon,s common stock (the "Common Stock") or ...
... BURLINGAME, Calif., Jan. 13, 2011 Collaborative Drug Discovery, Inc. ... has extended its previous grant to CDD to create a ... drugs against tuberculosis (TB). The TB bacillus infects approximately one ... 1.5 million people every year. Over the past ...
Cached Medicine Technology:Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 3Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 4Collaborative Drug Discovery Receives New Funding to Support Tuberculosis Drug Discovery Screening Efforts and Industrial-Academic Collaborations 2
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
... II lead series are silicon rubber ... the longevity of the pacemaker system ... high impedance of the lead as ... surface, combined with the elution of ...
CapSure SP endocardial tined pacing leads combine the steroid-eluting technology of the CapSure generation of leads with the platinization technology of Target Tip leads, to provide stable, low pacin...
Selute Picotip Atrial-J steroid eluting passive fixation lead...
Medicine Products: